Director, Oligonucleotide Therapeutics
PhD in structural immunology from National Institute of Immunology, New Delhi, India. Postdoctoral research in chemically modified RNA therapeutics at Albert Einstein College of Medicine, NY.
Prior to Insitro I worked at Regeneron Pharmaceuticals where I built and led Regeneron’s Nucleic Acid Therapeutics group under Regenron Genetics Medicine (RGM)
Leading oligonucleotide drug discovery and development across targets and therapeutic areas.